Skip to search formSkip to main contentSkip to account menu

AS 924

Known as: AS-924 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

ceftizoxime alapivoxil

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
AS-924, a novel, orally active, bifunctional prodrug of ceftizoxime: physicochemical properties, oral absorption in animals, and antibacterial activity.
2001
2001
Pharmacokinetics of cefcapene pivoxil and AS-924 in gastrectomized patients.
2001
2001
Effect of antacid pretreatment on the pharmacokinetics of AS-924, a novel ester-type cephem antibiotic--comparison with cefteram-pivoxil.
2001
2001
Effects of gastrointestinal stimulant and suppressant pretreatment on the pharmacokinetics of AS-924, a novel ester-type cephem antibiotic.
1999
1999
AS-924, a novel orally active bifunctional prodrug of ceftizoxime. Synthesis and relationship between physicochemical properties and oral absorption.
Ceftizoxime (CZX), a parenteral cephalosporin, has potent and broad antibacterial activity. To improve its oral absorption, we… 
1999
1999
AS-924, a novel bifunctional prodrug of ceftizoxime.
To improve the oral absorption of ceftizoxime (CZX), 7beta-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]- 3-cephem-4… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)